StockNews.com started coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a research note released on Saturday morning. The brokerage issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Price Performance Shares of Brooklyn ImmunoTherapeutics stock opened at $1.56 on Friday. The firm has a fifty day moving average price of $1.83 and […]